Savara SVRA
NASDAQ SVRA
$4.81 -0.24 (-4.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Savara (SVRA) Price to Sales (2017 - 2022)

Updated

Savara's (SVRA) Price to Sales came in at 200127.67 for Q1 2022.

Analysis

Savara (SVRA) Price to Sales (2017 - 2022) Analysis & Trends

For FY2020, Savara's Price to Sales stood at 242.32.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Savara 987.97 Mn 987.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 200,127.67
Dec 31, 2021 550.22
Sep 30, 2021 819.34
Dec 31, 2020 242.32
Sep 30, 2020 364.27
Sep 30, 2017 570.10
Jun 30, 2017 182.45
API Access

Savara Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=SVRA&period=max&api_key=YOUR_API_KEY